Revance Therapeutics | 4:持股變動聲明-高管 Hollander David
Revance Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-GIC Private Limited(0%)
Revance Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Capital World Investors(0.0%)
Revance Therapeutics | SC 13G:超過5%持股股東披露文件-Beryl Capital Management LLC(1.6%),Beryl Capital Management LP(1.6%)等
Revance Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Capital World Investors(6.6%)
Revance Therapeutics | 4:持股變動聲明-高管 Foley Mark J
Revance Therapeutics | 4:持股變動聲明-高管 Schilke Tobin
Revance Therapeutics | 4:持股變動聲明-董事 Ware Olivia C
Revance Therapeutics | 4:持股變動聲明-董事 Russell Angus C.
Revance Therapeutics | 4:持股變動聲明-董事 Nolet Chris
Revance Therapeutics | 4:持股變動聲明-董事 Kolaja Carey OConnor
Revance Therapeutics | 4:持股變動聲明-董事 Gangolli Julian S
Revance Therapeutics | 4:持股變動聲明-董事 Coric Vlad
Revance Therapeutics | 4:持股變動聲明-董事 Beraud Jill
Revance Therapeutics | 4:持股變動聲明-高管 Jordan Erica
Revance Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-JPMORGAN CHASE & CO.(2.6%)
Revance Therapeutics | 4:持股變動聲明-高管 Sjuts Dustin S
Revance Therapeutics | 4:持股變動聲明-高管 Moxie Dwight
Revance Therapeutics | 4:持股變動聲明-高管 Schilke Tobin
Revance Therapeutics | 4:持股變動聲明-高管 Foley Mark J